Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project
NCT02613637 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2017-02-24
Summary
Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly Diagnosed or Existent Lung Cancer
The LuCa Biology and Outcome (BiO)-Project
Conditions
Interventions
- OTHER
-
Registry
Sponsors & Collaborators
-
University of Ulm
lead OTHER
Principal Investigators
-
Lars Bullinger, MD · University Hospital of Ulm
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2024-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Oral Microbiome Diagnostics of Lung Cancer
NCT06270992 ·Status: RECRUITING
-
Ambispective Registry of Patients Affected by Lung Cancer
NCT07274163 ·Status: RECRUITING
-
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach(Radiogenomics-Lung)
NCT06500312 ·Status: RECRUITING
-
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383 ·Status: RECRUITING
-
Lung Cancer Registry for Lung Cancer Patients
NCT03276429 ·Status: COMPLETED
-
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
NCT06252233 ·Status: RECRUITING ·Phase: NA
-
Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization
NCT06531343 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring
NCT02437760 ·Status: UNKNOWN
-
Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
NCT01799395 ·Status: TERMINATED
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Health Outcomes and Costs (HOC) in Lung Cancer (LC)
NCT02363101 ·Status: UNKNOWN
-
Tumour Registry Lung Cancer (TLK)
NCT01192919 ·Status: COMPLETED
-
Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)
NCT06193239 ·Status: RECRUITING ·Phase: PHASE2
-
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
NCT06800586 ·Status: RECRUITING
-
Metabolomic Analysis of Lung Cancer
NCT00263731 ·Status: COMPLETED
-
Understanding Lung Cancer Related Risk Factors and Their Impact
NCT06473870 ·Status: NOT_YET_RECRUITING
-
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.
NCT06163846 ·Status: RECRUITING
-
Clinical and Molecular Staging of Lung Cancer Stages I and IIp
NCT03286036 ·Status: UNKNOWN
-
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
NCT06331975 ·Status: COMPLETED ·Phase: NA
-
Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology
NCT02123797 ·Status: COMPLETED
-
CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology
NCT03940846 ·Status: UNKNOWN
-
Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone
NCT06259461 ·Status: ACTIVE_NOT_RECRUITING
-
Artificial Intelligence in Lung Cancer Screening
NCT06444373 ·Status: COMPLETED
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED